Loss of Appetite and Nausea Heart failure can reduce blood flow to the digestive system, causing feelings of fullness, nausea, or loss of appetite. These symptoms are often ignored or attributed ...

Heart failure is one among the many complications of CVD, which significantly impairs the quality of life, leaving patients breathless, fatigued, and often unable to carry out simple daily tasks.

Advances in heart failure treatment have reduced hospitalizations by up to 30% and extended lives by years. Learn about prevention strategies and research developments.

Studies of the epidemiology of heart failure in the general population can inform assessments of disease burden, research, public health policy and health system care delivery. We performed a ...

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study missed one of its three endpoints — a larger trial is already planned.

Methods: Among 7581 participants in the Framingham Heart Study Third Generation (Gen 3, Visit 1) and Offspring (OS, Visit 7) cohorts, we investigated the association of plasma OPG levels with incident ...

Congenital heart failure as well as side effects of chemotherapy in children will be targets for this miracle therapy. Millions of children around the world suffer daily from these conditions.

Doctors and specialists at the Murdoch Children's Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure in children.

New gene therapy reverses heart failure in large animal model Date: December 10, 2024 Source: University of Utah Health Summary: In a single IV injection, a gene therapy targeting cBIN1 can ...

Systolic heart failure happens when the heart pumps at 40% or less of its ejection fraction. Ejection fraction measures how much blood the heart pumps with each contraction or beat.

Heart failure with mildly reduced or preserved ejection fraction often can be managed with medications called sodium-glucose co-transporter 2 or SGLT2 inhibitors, which help lower blood sugar.